Adamas Pharmaceuticals, Inc.
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
Adamas Pharmaceuticals, Inc. is a small pharmaceutical manufacturing company based in Emeryville, California, focused on developing medicines for neurological disorders. Its mission is to deliver innovative therapies aimed at reducing the burden of neurological disease on patients, their caregivers, and society. The company positions itself as fully integrated and intent on growing a portfolio of therapies across a spectrum of neurological conditions. In early 2021, Adamas announced FDA approval for a second indication of its Parkinson's disease treatment Gocovri, expanding its use to address off episodes. It also launched Picture More Time, a national disease-education campaign to raise awareness of motor complications in Parkinson's disease.